Basics |
Revolution Medicines, Inc.
|
IPO Date: |
February 13, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$6.89B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.82 | 2.74%
|
Avg Daily Range (30 D): |
$0.86 | 2.17%
|
Avg Daily Range (90 D): |
$0.82 | 2.14%
|
Institutional Daily Volume |
Avg Daily Volume: |
.81M |
Avg Daily Volume (30 D): |
1.55M |
Avg Daily Volume (90 D): |
1.34M |
Trade Size |
Avg Trade Size (Sh.): |
71 |
Avg Trade Size (Sh.) (30 D): |
59 |
Avg Trade Size (Sh.) (90 D): |
61 |
Institutional Trades |
Total Inst.Trades: |
4,154 |
Avg Inst. Trade: |
$2.94M |
Avg Inst. Trade (30 D): |
$4.2M |
Avg Inst. Trade (90 D): |
$3.73M |
Avg Inst. Trade Volume: |
.09M |
Avg Inst. Trades (Per Day): |
3 |
Market Closing Trades |
Avg Closing Trade: |
$5.35M |
Avg Closing Trade (30 D): |
$10.38M |
Avg Closing Trade (90 D): |
$9.71M |
Avg Closing Volume: |
167.86K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-4.01
|
$-1.13
|
$-1.13
|
Diluted EPS
|
$-4.01
|
$-1.13
|
$-1.13
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -697.51M
|
$ -213.42M
|
$ -194.57M
|
Operating Income / Loss
|
$ -789.43M
|
$ -240.76M
|
$ -216.31M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 45.79M
|
$ -209.51M
|
$ 342.61M
|
PE Ratio
|
|
|
|
|